Interferon alpha versus any other drug for chronic hepatitis D

Zaigham Abbas, Syed Salman Ali, Lubna Shazi

Research output: Contribution to journalArticlepeer-review


This is the protocol for a review and there is no abstract. The objectives are as follows: To compare the benefits and harms of interferon alpha as standard or pegylated plus other antivirals or other antivirals versus alpha as standard or as pegylated alone for people with chronic hepatitis D infection.

Original languageEnglish
Article numberCD011727
JournalCochrane Database of Systematic Reviews
Issue number6
Publication statusPublished - 2 Jun 2015
Externally publishedYes


Dive into the research topics of 'Interferon alpha versus any other drug for chronic hepatitis D'. Together they form a unique fingerprint.

Cite this